blood pressure medication

Researchers have identified a new potential treatment target for high blood pressure, a condition affecting over a billion people worldwide and a leading risk factor for heart disease and stroke. The discovery could open the door to new drug development beyond existing blood pressure medications. Details of the findings and their clinical significance remain limited.

The FDA has announced a new nationwide recall of a blood pressure medication. Few details beyond the announcement are available so far, including which specific drug, manufacturer, and lot numbers are affected, or the reason for the recall. Patients taking blood pressure medication are advised to watch for updates from the FDA and their pharmacies before making any changes to their treatment.

A recall of chlorthalidone, a widely prescribed blood pressure medication, is drawing attention after reports linked it to FDA dissolution testing failures. Dissolution testing checks whether a pill dissolves properly in the body, so failing tablets may not deliver the intended dose. Patients are advised not to stop taking their medication suddenly and to consult a pharmacist or doctor about alternatives.

New coverage reports that heart and kidney complications in patients with type 2 diabetes increase as the disease progresses over time. The finding underscores the cumulative toll of diabetes on cardiovascular and renal health and highlights the importance of long-term monitoring and management of blood sugar, blood pressure and kidney function in affected patients.

A new article reviews what scientific research actually says about the best time of day to take blood pressure medication, addressing a common question among patients. The debate stems from mixed findings in studies on whether morning or evening dosing better controls hypertension and reduces cardiovascular risk, leaving many patients unsure about their routine.